Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,127Revenue $M2.9Net Margin (%)-252.4Altman Z-Score55.3
Enterprise Value $M3,797EPS $-0.8Operating Margin %-273.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score5.7Pre-tax Margin (%)-252.4Higher ROA y-yY
Price/Book8.510-y EBITDA Growth Rate %--Quick Ratio26.7Cash flow > EarningsN
Price/Sales1935-y EBITDA Growth Rate %--Current Ratio26.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-15.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-17.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M85.4ROIC % (ttm)-109.8Gross Margin Increase y-yN

Gurus Latest Trades with NBIX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NBIXGeorge Soros 2013-09-30 Sold Out -0.03%$10.6 - $16.7
($13.79)
$ 48.32250%Sold Out0
NBIXGeorge Soros 2013-06-30 Buy 0.03%$10.9 - $13.57
($12.28)
$ 48.32293%New holding200,000
NBIXJoel Greenblatt 2012-12-31 Sold Out -0.13%$6.88 - $8.66
($7.6)
$ 48.32536%Sold Out0
NBIXJoel Greenblatt 2012-06-30 Add0.03%$6.31 - $8.06
($7.18)
$ 48.32573%Add 23.80%259,903
NBIXGeorge Soros 2012-06-30 Sold Out -0.02%$6.31 - $8.06
($7.18)
$ 48.32573%Sold Out0
NBIXJoel Greenblatt 2012-03-31 Buy 0.15%$7.33 - $9.79
($7.95)
$ 48.32508%New holding209,930
NBIXGeorge Soros 2012-03-31 Buy 0.02%$7.33 - $9.79
($7.95)
$ 48.32508%New holding150,000
NBIXGeorge Soros 2011-12-31 Sold Out -0.0018%$5.5 - $8.58
($6.76)
$ 48.32615%Sold Out0
NBIXGeorge Soros 2011-09-30 Reduce$5.59 - $8.44
($6.71)
$ 48.32620%Reduce 23.93%17,800
NBIXGeorge Soros 2011-06-30 Add$6.82 - $8.3
($7.54)
$ 48.32541%Add 90.24%23,400
NBIXGeorge Soros 2011-03-31 Add$6.47 - $7.84
($7.2)
$ 48.32571%Add 23.00%12,300
NBIXGeorge Soros 2010-12-31 Buy $5.99 - $8.53
($7.63)
$ 48.32533%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NBIX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MITCHELL W THOMASDirector 2015-06-23Sell15,000$49.35-2.09 view
OBrien Christopher FlintChief Medical Officer 2015-06-08Sell10,000$457.38 view
Grigoriadis Dimitri E.Chief Research Officer 2015-06-08Sell10,000$457.38 view
Coughlin Timothy PCFO 2015-06-08Sell60,000$45.087.19 view
Gano KyleSee Remarks 2015-06-01Sell38,230$42.1914.53 view
OBrien Christopher FlintChief Medical Officer 2015-06-01Sell10,000$42.214.5 view
GORMAN KEVIN CHARLESPresident and CEO 2015-03-24Sell40,000$41.5316.35 view
LYONS GARY ADirector 2015-03-24Sell30,000$41.5316.35 view
Coughlin Timothy PCFO 2015-03-20Sell40,000$44.498.61 view
Grigoriadis Dimitri E.Chief Research Officer 2015-02-23Sell20,000$4020.8 view

Quarterly/Annual Reports about NBIX:

News about NBIX:

Articles On GuruFocus.com
Weekly Insider Sells Highlight: ORCL, TWC, FB, NBIX Jan 13 2014 
5 Strong Healthcare Stocks For 2012 Mar 24 2012 
Consider These 5 Healthcare Stocks Now Mar 21 2012 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,320 Shares Mar 02 2011 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,400 Shares Mar 02 2011 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Oct 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Jul 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Apr 29 2010 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,650 Shares Mar 03 2010 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,609 Shares Mar 03 2010 

More From Other Websites
Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX)... Jun 25 2015
More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks Jun 24 2015
Aeropostale, SouFun, Cyberark Led Monday's After-Hours Movers Jun 09 2015
Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia Jun 08 2015
Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia Jun 08 2015
Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer Jun 02 2015
Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer Jun 02 2015
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 01 2015
Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference May 27 2015
Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference May 27 2015
Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015 May 21 2015
Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015 May 12 2015
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May 08 2015
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May 08 2015
Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical... May 07 2015
NEUROCRINE BIOSCIENCES INC Financials May 06 2015
10-Q for Neurocrine Biosciences, Inc. May 04 2015
Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical... May 04 2015
Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference Apr 30 2015
Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference Apr 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK